Navigation Links
KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification
Date:10/15/2009

to effectively fight cancer. In turn, individualized therapeutic strategies could then improve overall treatment outcome for malignant diseases, such as AML.

New treatment options, such as Nexavar, are responsible for the progress which has been achieved in recent years in the fight against cancer. Yet we still have a long way to go until a truly personalized medicine, based on validated biomarkers, will become a reality. That is the reason why we need to further investigate new diagnostic and treatment approaches. The co-operation between the business unit oncology at Bayer Vital in Leverkusen and Kinaxo Biotechnologies in Martinsried with Germany as the prime research site gives us a unique chance to substantially contribute to the improvement of cancer therapies. Both partners aim at investigating innovative technologies (such as phosphoproteomics) and targeted therapies (such as kinase inhibitors) which - in conjunction - should allow more effective cancer treatments and, thus, provide more hope to cancer patients, says Dr. Erich Enghofer, Head of the Business Unit Oncology.


About KINAXO - www.kinaxo.com
KINAXO Biotechnologies GmbH is a privately-held biotechnology company based in Munich/ Martinsried, Germany. As a spin-off of the Max Planck Institute of Biochemistry on Martinsried, we closely cooperate with several of the Institutes most outstanding scientists in the field of chemical proteomics and quantitative mass spectrometry. KINAXOs technology portfolio delivers direct insights into a compounds cellular interactions and its mode of action and is routinely applied to decrease drug development times and improve therapeutic strategies. KINAXO has several ongoing collaborations with major pharmaceutical companies.

About Nexavar
Nexavar, an oral anti-cancer drug, is currently approved in more than 70 countries for the treatment of liver ca
'/>"/>

b3c newswire

Page: 1 2 3 4

Related biology news :

1. KINAXOs Cellular Target Profiling reveals mTOR as a new target of Celebrex
2. KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue
3. VIB and Bayer join forces for plant research
4. Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience
5. ERS-2 data vital for maritime security
6. New discovery on role of vital protein that fights meningitis
7. Gap junction protein vital to successful pregnancy, researchers find
8. Herbicide-resistant grape could revitalize Midwest wine industry
9. Loggerhead release to provide vital information to scientific community
10. Researchers first to see reactive oxygen species in vital enzyme
11. Understanding phosphorus in soils is vital to proper management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... Md. , April 2, 2015 At ... Salt Lake City , the American College ... of five new directors to its Board.  Members of ... the ACMG and for forming and advancing its policies ... medical genetics profession. "It,s an eventful time ...
(Date:4/1/2015)... 1, 2015   Medisafe ™, the leading global ... iOS and Android smartphones and ... into the platform to allow patients to track and ... first time, patients will be able to visualize in ... important biometrics, such as glucose levels and blood pressure. ...
(Date:3/26/2015)... The Granite Club, ... club, today announced it has implemented a state-of-the-art access ... for members and staff, while restricting access to authorized ... selected FST,s IMID Access system because it has the ... and staff, in addition to unparalleled security," said ...
Breaking Biology News(10 mins):American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... not affect how long you will live. Instead it is how ... reveals research from the University of Gothenburg recently published in the ... that people with parents who lived to be very old are ... that,s just not true our study shows that hereditary factors ...
... be a problem of towns and cities but new research published ... shows that binge drinking in rural areas is more of ... Psychiatric University Clinic Erlangen, looked at the drinking patterns of over ... more than 93% of the young people from the countryside and ...
... Kyoto, Japan -- In a complex feat of ... the University of Oxford have succeeded in creating a ... be observed in real time. The results, appearing in ... the door to the development of advanced drug delivery ...
Cached Biology News:Lifestyle affects life expectancy more than genetics 2
(Date:4/20/2015)... , April 20, 2015 PointCross Life ... Ltd. to provide an integrated Big Data and globally ... biomarkers collected in the context of clinical trials and ... precise or multi-targeted drug candidates, stratified patient selection and ... progression free survival. Highlighting the timing ...
(Date:4/20/2015)... ANGELES , April 20, 2015  "Everybody is ... we do to patients is frankly brutal. We,ve got ... in a cancer ward, or witnessed a loved one ... you,ve witnessed firsthand the devastation chemotherapy and other treatments ... most people want to give up and succumb to ...
(Date:4/20/2015)... 2015 /CNW/ - Portage Biotech Inc. ("Portage" or "the ... pleased to announce that its wholly owned subsidiary, Portage ... that showed one of its proprietary human-derived CPP sequences ... through inhibition of NFkB signalling even if administered when ... of the blood brain barrier (BBB) in mice was ...
(Date:4/20/2015)... 20, 2015   Meditope Biosciences, Inc ., a ... technology, today announced presentation of data demonstrating the use ... antibody-drug conjugates (ADCs). The data were presented in an abstract ... 18-22 in Philadelphia . ... point to the many commercial applications that may be ...
Breaking Biology Technology:PointCross Life Sciences and InterpretOmics partner for Clinical and Genomic Biomarker Management for Drug Development 2Is Dr. Craig Dionne the Steve Jobs of Cancer Research? 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2
... IL - SecurePipe , a provider of ... an agreement to acquire the assets of Mycom's ... management technologies from Cincinnati-based Mycom Group, Inc. , ,SecurePipe ... sectors such as manufacturing, education, health care and financial ...
... Madison, Wis. - R&D Magazine has ... a 2005 R&D 100 Award, which recognizes the most ... past year. , ,The VANTEC-2000 system is an advanced ... science, materials science and nanotechnology research fields. It enables ...
... been utilized by thousands of U.S. companies since the ... fact, lawmakers in more than 35 states have introduced ... as an effective cost-cutting tool has begun to soar. ... offshore outsourcing, it was often viewed as ...
Cached Biology Technology:Consider the legal issues before outsourcing offshore 2Consider the legal issues before outsourcing offshore 3Consider the legal issues before outsourcing offshore 4Consider the legal issues before outsourcing offshore 5
... amber to slightly cloudy liquid. Yellow, ... per set, each containing 10 ml ... the following proportions by weight: 85% ... monooleate emulsifier), and 0.1% Mycobacterium ...
... been many modifications to the original formulas in ... still play an important role in tissue,culture. A ... and osmotic balance in the medium and to ... ions, is as valuable today as when it ...
Request Info...
... ion trap mass spectrometer enables high-throughput solutions ... LXQ linear ion trap mass spectrometer is ... delivering the fast cycle time and increased ... at an attractive price. The combination ...
Biology Products: